These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1818999)

  • 1. Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors.
    MacFadyen RJ; Lees KR; Reid JL
    J Hypertens Suppl; 1991 Dec; 9(6):S376-7. PubMed ID: 1818999
    [No Abstract]   [Full Text] [Related]  

  • 2. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.
    Brown MJ; Dickerson JE
    J Hypertens Suppl; 1991 Dec; 9(6):S362-3. PubMed ID: 1687874
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the dose-effect relationship of perindopril in the treatment of hypertension.
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Clin Exp Hypertens A; 1989; 11 Suppl 2():521-34. PubMed ID: 2605801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the dose-effect relationship of perindopril in the treatment of arterial hypertension].
    Luccioni R; Frances Y; Gass R; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():43-50. PubMed ID: 2505712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Administration of captopril (aceten++, ++"Vokhardt"++) in hypertension and congestive heart failure].
    Balakhonova NP; Avdeev VG; Kuznetsov NE; Liapon DO; Senchikhin PV
    Klin Med (Mosk); 1997; 75(1):42-3. PubMed ID: 9082059
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood pressure response to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Reid JL; MacFadyen RJ; Squire IB; Lees KR
    Am J Cardiol; 1993 Jun; 71(17):57E-60E. PubMed ID: 8392282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of blood pressure control with once daily administration of enalapril and perindopril.
    Anderson A; Morgan O; Morgan T
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):371-3. PubMed ID: 8031555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
    de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
    J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril versus perindopril: a double blind study in essential hypertension.
    Lees KR; Reid JL; Scott MG; Hosie J; Herpin D; Santoni JP
    J Hum Hypertens; 1989 Feb; 3(1):17-22. PubMed ID: 2657055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting ex vivo inhibition by perindopril of rat vascular response to angiotensin I.
    Ishigai Y; Fukuzawa A; Chiba K; Irie K; Shibano T
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):633-8. PubMed ID: 7746024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
    Kramkowski K; Mogielnicki A; Chabielska E; Cylwik D; Buczko W
    Thromb Res; 2006; 117(5):557-61. PubMed ID: 15985287
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
    Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
    J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal delivery of Angiotensin Converting Enzyme inhibitors.
    Helal F; Lane ME
    Eur J Pharm Biopharm; 2014 Sep; 88(1):1-7. PubMed ID: 24657822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of studies on the clinical pharmacodynamics of cilazapril.
    Belz GG; Breithaupt K; Erb K
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Volume of the extracellular liquid and renal function during short-term administration of angiotensin converting enzyme inhibitors in essential hypertension].
    Samà B; Semplicini A; Buzzacarini F; Rubino N; Marzola M; Mozzato MG; Casolino P; Pessina AC
    G Ital Cardiol; 1989 May; 19(5):428-32. PubMed ID: 2670657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition decreases systolic blood pressure more than diastolic pressure as shown by ambulatory blood pressure monitoring.
    Asmar RG; Pannier BM; Santoni JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S79-81. PubMed ID: 3225692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.